• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者的脑白质高信号:系统评价和荟萃分析。

White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.

机构信息

Department of Medicine, Division of Neurology, University of Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3, Canada.

Neuroscience and Mental Health Institute, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada.

出版信息

J Neurol Sci. 2021 Jul 15;426:117481. doi: 10.1016/j.jns.2021.117481. Epub 2021 May 4.

DOI:10.1016/j.jns.2021.117481
PMID:33975191
Abstract

INTRODUCTION

Mechanisms driving neurodegeneration in Parkinson's disease (PD) are unclear and neurovascular dysfunction may be a contributing factor. White matter hyperintensities (WMH) are commonly found on brain MRI in patients with PD. It is controversial if they are more prevalent or more severe in PD compared with controls. This systematic review aims to answer this question.

METHODS

A systematic search of electronic databases was conducted for studies of WMH in patients with PD. A qualitative synthesis was done for studies reporting WMH prevalence or WMH scores on a visual rating scale (VRS). In studies reporting total WMH volume, the difference between patients with PD and controls was pooled using random effects meta-analysis.

RESULTS

Among 3860 subjects from 24 studies, 2360 were cases and 1500 controls. Fifteen studies reported WMH scores and four studies reported the prevalence of WMH. On VRS, five studies reported no difference in WMH scores, three found higher WMH scores in PD compared to controls, three reported increased WMH scores either in periventricular or deep white matter, and four reported higher scores only in PD with dementia. In studies reporting WMH volume, there was no difference between patients with PD and controls (pooled standardized mean difference = 0.1, 95%CI: -0.1-0.4, I = 81%).

CONCLUSION

WMH are not more prevalent or severe in patients with PD than in age-matched controls. PD dementia may have more severe WMH compared to controls and PD with normal cognition. Prospective studies using standardized methods of WMH assessment are needed.

摘要

简介

帕金森病 (PD) 中神经退行性变的机制尚不清楚,神经血管功能障碍可能是一个促成因素。在 PD 患者的脑部磁共振成像 (MRI) 上通常可以发现脑白质高信号 (WMH)。与对照组相比,PD 患者的 WMH 是否更常见或更严重存在争议。本系统评价旨在回答这个问题。

方法

对 PD 患者 WMH 的研究进行了电子数据库的系统搜索。对报告 WMH 患病率或视觉评分量表 (VRS) 上 WMH 评分的研究进行了定性综合。在报告总 WMH 体积的研究中,使用随机效应荟萃分析汇总了 PD 患者与对照组之间的差异。

结果

在 24 项研究的 3860 名受试者中,2360 名是病例,1500 名是对照。15 项研究报告了 WMH 评分,4 项研究报告了 WMH 的患病率。在 VRS 上,有 5 项研究报告 WMH 评分无差异,3 项研究发现 PD 患者的 WMH 评分高于对照组,3 项研究报告脑室周围或深部白质的 WMH 评分增加,4 项研究报告仅在 PD 合并痴呆患者中评分较高。报告 WMH 体积的研究中,PD 患者与对照组之间无差异(合并标准化均数差=0.1,95%CI:-0.1-0.4,I=81%)。

结论

与年龄匹配的对照组相比,PD 患者的 WMH 并不更常见或更严重。PD 痴呆患者的 WMH 可能比对照组和认知正常的 PD 患者更严重。需要使用 WMH 评估的标准化方法进行前瞻性研究。

相似文献

1
White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis.帕金森病患者的脑白质高信号:系统评价和荟萃分析。
J Neurol Sci. 2021 Jul 15;426:117481. doi: 10.1016/j.jns.2021.117481. Epub 2021 May 4.
2
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
3
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
4
Exercise versus airway clearance techniques for people with cystic fibrosis.运动与气道廓清技术治疗囊性纤维化。
Cochrane Database Syst Rev. 2022 Jun 22;6(6):CD013285. doi: 10.1002/14651858.CD013285.pub2.
5
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
6
White matter hyperintensities and the risk of vascular dementia: a systematic review and meta-analysis.脑白质高信号与血管性痴呆风险:一项系统评价和荟萃分析。
PeerJ. 2025 Jun 16;13:e19460. doi: 10.7717/peerj.19460. eCollection 2025.
7
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Heliox for croup in children.氦氧混合气治疗儿童喉炎。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD006822. doi: 10.1002/14651858.CD006822.pub6.
10
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.

引用本文的文献

1
Is age-related myelinodegenerative change an initial risk factor of neurodegenerative diseases?与年龄相关的髓鞘变性改变是神经退行性疾病的初始危险因素吗?
Neural Regen Res. 2026 Feb 1;21(2):648-658. doi: 10.4103/NRR.NRR-D-24-00848. Epub 2025 Jan 13.
2
Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson's disease and multiple system atrophy: a case control study.基于白质高信号的早期至中期帕金森病和多系统萎缩患者多巴胺转运体可用性:一项病例对照研究。
Neurol Sci. 2025 Feb;46(2):751-760. doi: 10.1007/s10072-024-07856-3. Epub 2024 Oct 30.
3
3D Models as a Source for Neuroanatomy Education: A Stepwise White Matter Dissection Using 3D Images and Photogrammetry Scans.
3D 模型作为神经解剖学教育资源:使用 3D 图像和摄影测量扫描进行逐步的白质解剖。
Brain Topogr. 2024 Nov;37(6):947-960. doi: 10.1007/s10548-024-01058-y. Epub 2024 May 16.
4
Neurocognitive Impairment and Social Cognition in Parkinson's Disease Patients.帕金森病患者的神经认知障碍与社会认知
Neurol Int. 2024 Apr 16;16(2):432-449. doi: 10.3390/neurolint16020032.
5
Structural and Functional Changes in Mild Cognitive Impairment in Parkinson's Disease.帕金森病轻度认知障碍的结构和功能变化。
Medicina (Kaunas). 2023 Dec 24;60(1):33. doi: 10.3390/medicina60010033.
6
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.帕金森病认知障碍的病理生物学:挑战与展望。
Int J Mol Sci. 2023 Dec 29;25(1):498. doi: 10.3390/ijms25010498.
7
Association between the blood pressure variability and cognitive decline in Parkinson's disease.血压变异性与帕金森病认知衰退的关系。
Brain Behav. 2023 Dec;13(12):e3319. doi: 10.1002/brb3.3319. Epub 2023 Nov 15.
8
White matter changes in Parkinson's disease.帕金森病中的白质变化。
NPJ Parkinsons Dis. 2023 Oct 31;9(1):150. doi: 10.1038/s41531-023-00592-z.
9
White matter hyperintensities associated with impulse control disorders in Parkinson's Disease.与帕金森病冲动控制障碍相关的脑白质高信号。
Sci Rep. 2023 Jun 30;13(1):10594. doi: 10.1038/s41598-023-37054-8.
10
Regional white matter hyperintensity volume in Parkinson's disease and associations with the motor signs.帕金森病患者的区域性脑白质高信号体积与运动症状的相关性。
Ann Clin Transl Neurol. 2023 Sep;10(9):1502-1512. doi: 10.1002/acn3.51839. Epub 2023 Jun 24.